Literature DB >> 18689361

Dietary monounsaturated fat activates metabolic pathways for triglyceride-rich lipoproteins that involve apolipoproteins E and C-III.

Chunyu Zheng1, Christina Khoo, Jeremy Furtado, Katsunori Ikewaki, Frank M Sacks.   

Abstract

BACKGROUND: Dietary monounsaturated fat (MUFA) and complex carbohydrates have different effects on triglyceride-rich lipoprotein (TRL) metabolism.
OBJECTIVE: We hypothesized that apolipoprotein (apo) E and apo C-III might be involved in these dietary effects because of their crucial role in TRL metabolism.
DESIGN: Twelve adults consumed, for 3 wk each, 2 isocaloric diets: first a carbohydrate-rich diet (48% complex carbohydrate, 8% MUFAs) and then a MUFA-rich diet (31% complex carbohydrate, 24% MUFAs) 12 mo later. The dietary composition of other macronutrients in the 2 diets was similar. Body weight was kept constant. Postprandial apo B kinetic studies using stable-isotope tracers were performed after each dietary intervention. Multiple VLDL, intermediate-density lipoprotein (IDL), and LDL fractions were prepared on the basis of apo E and apo C-III contents.
RESULTS: The MUFA diet increased by approximately 4-6-fold, the secretion of VLDLs and IDLs containing both apo E and apo C-III (E+CIII+) (P < 0.05). These are TRLs that mostly cleared from the circulation and are minor precursors of LDL. The MUFA diet also decreased by 60% (P < 0.05) the secretion of the TRLs without apo E or apo C-III (major precursors of LDL in plasma) and decreased their flux to LDLs. Total LDL flux did not change because the MUFA diet increased the flux to LDL from E-CIII+ TRLs, a process that requires the removal of apo C-III. In addition, the MUFA diet significantly increased the TRL fractional catabolic rate by 50% and doubled the percentage of TRLs that were cleared rather than being converted to LDLs.
CONCLUSION: MUFA intake activates synthetic and rapid catabolic pathways for TRL metabolism that involve apo E and apo C-III and suppresses the metabolism of more slowly metabolized VLDLs and IDLs, which do not contain these apolipoproteins.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18689361      PMCID: PMC2547880          DOI: 10.1093/ajcn/88.2.272

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  36 in total

1.  Kinetics of triglyceride turnover of very low density lipoproteins of human plasma.

Authors:  G M Reaven; D B Hill; R C Gross; J W Farquhar
Journal:  J Clin Invest       Date:  1965-11       Impact factor: 14.808

2.  Differential metabolism of human VLDL according to content of ApoE and ApoC-III.

Authors:  K Tomiyasu; B W Walsh; K Ikewaki; H Judge; F M Sacks
Journal:  Arterioscler Thromb Vasc Biol       Date:  2001-09       Impact factor: 8.311

3.  Effect of a high carbohydrate diet on apoprotein-B catabolism in man.

Authors:  H N Ginsberg; N A Le; J Melish; D Steinberg; W V Brown
Journal:  Metabolism       Date:  1981-04       Impact factor: 8.694

4.  Purification and quantitation of the human plasma lipoprotein carrying the Lp(a) antigen.

Authors:  C Ehnholm; H Garoff; K Simons; H Aro
Journal:  Biochim Biophys Acta       Date:  1971-05-25

5.  Sucrose-induced changes in VLDL- and LDL-B apoprotein removal rates.

Authors:  P J Nestel; M Reardon; N H Fidge
Journal:  Metabolism       Date:  1979-05       Impact factor: 8.694

6.  Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials.

Authors:  Ronald P Mensink; Peter L Zock; Arnold D M Kester; Martijn B Katan
Journal:  Am J Clin Nutr       Date:  2003-05       Impact factor: 7.045

Review 7.  Apolipoprotein E: far more than a lipid transport protein.

Authors:  R W Mahley; S C Rall
Journal:  Annu Rev Genomics Hum Genet       Date:  2000       Impact factor: 8.929

8.  The estradiol-stimulated lipoprotein receptor of rat liver. A binding site that membrane mediates the uptake of rat lipoproteins containing apoproteins B and E.

Authors:  E E Windler; P T Kovanen; Y S Chao; M S Brown; R J Havel; J L Goldstein
Journal:  J Biol Chem       Date:  1980-11-10       Impact factor: 5.157

9.  Very low density lipoprotein triglyceride transport in type IV hyperlipoproteinemia and the effects of carbohydrate-rich diets.

Authors:  S H Quarfordt; A Frank; D M Shames; M Berman; D Steinberg
Journal:  J Clin Invest       Date:  1970-12       Impact factor: 14.808

10.  Dissociation of apoprotein B and triglyceride production in very-low-density lipoproteins.

Authors:  J Melish; N A Le; H Ginsberg; D Steinberg; W V Brown
Journal:  Am J Physiol       Date:  1980-11
View more
  18 in total

1.  Effects of Replacing Dietary Monounsaturated Fat With Carbohydrate on HDL (High-Density Lipoprotein) Protein Metabolism and Proteome Composition in Humans.

Authors:  Allison B Andraski; Sasha A Singh; Lang Ho Lee; Hideyuki Higashi; Nathaniel Smith; Bo Zhang; Masanori Aikawa; Frank M Sacks
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-09-26       Impact factor: 8.311

2.  Complexities of plasma apolipoprotein C-III metabolism.

Authors:  Frank M Sacks; Chunyu Zheng; Jeffrey S Cohn
Journal:  J Lipid Res       Date:  2011-03-18       Impact factor: 5.922

3.  Missense mutation in APOC3 within the C-terminal lipid binding domain of human ApoC-III results in impaired assembly and secretion of triacylglycerol-rich very low density lipoproteins: evidence that ApoC-III plays a major role in the formation of lipid precursors within the microsomal lumen.

Authors:  Wen Qin; Meenakshi Sundaram; Yuwei Wang; Hu Zhou; Shumei Zhong; Chia-Ching Chang; Sanjay Manhas; Erik F Yao; Robin J Parks; Pamela J McFie; Scot J Stone; Zhenghui G Jiang; Congrong Wang; Daniel Figeys; Weiping Jia; Zemin Yao
Journal:  J Biol Chem       Date:  2011-06-15       Impact factor: 5.157

4.  Apolipoprotein C-III and the metabolic basis for hypertriglyceridemia and the dense low-density lipoprotein phenotype.

Authors:  Chunyu Zheng; Christina Khoo; Jeremy Furtado; Frank M Sacks
Journal:  Circulation       Date:  2010-04-05       Impact factor: 29.690

5.  Metabolism of apolipoprotein A-II containing triglyceride rich ApoB lipoproteins in humans.

Authors:  Nirav K Desai; Esther M Ooi; Paul D Mitchell; Jeremy Furtado; Frank M Sacks
Journal:  Atherosclerosis       Date:  2015-05-19       Impact factor: 5.162

Review 6.  The crucial roles of apolipoproteins E and C-III in apoB lipoprotein metabolism in normolipidemia and hypertriglyceridemia.

Authors:  Frank M Sacks
Journal:  Curr Opin Lipidol       Date:  2015-02       Impact factor: 4.776

7.  Effects of variations in the APOA1/C3/A4/A5 gene cluster on different parameters of postprandial lipid metabolism in healthy young men.

Authors:  Javier Delgado-Lista; Francisco Perez-Jimenez; Juan Ruano; Pablo Perez-Martinez; Francisco Fuentes; Juan Criado-Garcia; Laurence D Parnell; Antonio Garcia-Rios; Jose M Ordovas; Jose Lopez-Miranda
Journal:  J Lipid Res       Date:  2010-01       Impact factor: 5.922

8.  Expression of apolipoprotein C-III in McA-RH7777 cells enhances VLDL assembly and secretion under lipid-rich conditions.

Authors:  Meenakshi Sundaram; Shumei Zhong; Maroun Bou Khalil; Philip H Links; Yang Zhao; Jahangir Iqbal; M Mahmood Hussain; Robin J Parks; Yuwei Wang; Zemin Yao
Journal:  J Lipid Res       Date:  2010-01       Impact factor: 5.922

9.  Functional analysis of the missense APOC3 mutation Ala23Thr associated with human hypotriglyceridemia.

Authors:  Meenakshi Sundaram; Shumei Zhong; Maroun Bou Khalil; Hu Zhou; Zhenghui G Jiang; Yang Zhao; Jahangir Iqbal; M Mahmood Hussain; Daniel Figeys; Yuwei Wang; Zemin Yao
Journal:  J Lipid Res       Date:  2010-01-23       Impact factor: 5.922

10.  Metabolism of very-low-density lipoprotein and low-density lipoprotein containing apolipoprotein C-III and not other small apolipoproteins.

Authors:  Carlos O Mendivil; Chunyu Zheng; Jeremy Furtado; Julian Lel; Frank M Sacks
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-11-12       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.